Global Rheometer and Viscometer Market Size

Rheometer Viscometer Market Analysis

The rheometer and viscometer market is expected to register a CAGR of 4% over the forecast period.

COVID-19 has influenced every element of society and it has impacted the healthcare and medical device industry, and so has affected the rheometer and viscometer devices market on a global scale. The government regulations and lockdown led to a substantial decline in overall non-emergency treatments, which in turn decreased the usage of viscometers and rheometers. Although cardiology departments offered emergency and outpatient treatments, the number of patient visits to hospitals declined dramatically in the initial month of COVID-19. An article titled, "The role of plasma viscosity testing in managing COVID-19 disease" published in May 2021 reported that plasma viscosity significantly got increased in COVID-19 patients and thus, viscosity become an important, inexpensive and accurate test to identify the individual is SARS-CoV-2 positive or not. Thus, sales of rheometer and viscometer devices dropped initially, but after a few months, the market witnessed significant growth.

The factors that are supposed to be driving this market are the expansion of petrochemical and material manufacturing industries, technological advancements in rheometers and viscometers, and the rising global burden of target diseases. Viscometers have important applications in real-time quality and process control for a wide range of industrial processes, e.g. in the food, chemical, pharmaceutical, and petrochemical industries. For instance, an article titled, "Using texture analyzer to characterize pecan and olive oil tactile properties, compare to viscometer analysis, and link to fatty acid profile and total polyphenols" published in February 2022, reported that viscometer is an important quality control instrument used in checking the viscosity of different food consumable oil, and thus an important factor to check the fatty acid profile of oils.

The rising global burden of target diseases is also driving this market. The engineering of blood viscometers for the diagnosis, prognosis, and prevention of cardiovascular and other diseases has been the subject of significant research interest. These micro-blood viscometers are advantageous because they use very small sample volumes for quick, routine clinical purposes. For instance, in May 2021 an article titled, "Microfluidic viscometers for biochemical and biomedical applications: A review' reported that diabetes can be monitored by comparing the deviation in the viscosity of the blood serum with the normal person and it was concluded that the change in the viscosity was not dependent on age, obesity, gender, or any other disease. The viscosity of the blood is an important parameter; measuring it has a wide scope in disease diagnostics. The increasing burden of global diseases is also fueling the growth of the market.

Also, the new product launches are constantly propelling the growth of the studied market. For instance, in December 2021, the PCE instrument launched a new Krebs-Stormer viscometer with a touchscreen, the PCE-REVI-8. The new viscosity meter allows quick testing of samples not only at the laboratory but also directly in production or storage rooms under suitable environmental conditions. It is new is a practical device for convenient measurements.

Thus, due to the above-mentioned factors, the market is expected to show significant growth over the forecast period. However, the high cost of the viscometer and rheometer may slow down its growth.